Rosai-Dorfman Disease: Imaging and Updates
Although Rosai-Dorfman disease has nonspecific imaging features, imaging remains essential for delineating disease extent, predicting prognosis, and assessing treatment response once the diagnosis is established through integrated clinical, imaging, and histopathologic evaluation.
Authors
- Amar Shah (ORCID: https://orcid.org/0000-0003-3195-4491)
- Carol Holman (ORCID: https://orcid.org/0000-0002-5748-9914)
- Yashant Aswani (ORCID: https://orcid.org/0000-0001-6994-8826)
- Malak Itani (ORCID: https://orcid.org/0000-0002-8964-6400)
- Akira Kawashima (ORCID: https://orcid.org/0000-0003-4686-8369)
- Eli Diamond (ORCID: https://orcid.org/0000-0003-2170-910X)
- Aarti Sekhar (ORCID: https://orcid.org/0000-0002-2783-7703)
- Sedat Giray Kandemirli (ORCID: https://orcid.org/0000-0002-3976-4062)
- Mohd Javed Saifullah Shaikh (ORCID: https://orcid.org/0000-0002-5615-4813)
- Zubin Vicky Driver (ORCID: https://orcid.org/0009-0009-1751-0983)
- Leonardo Gomes Marcelino (ORCID: https://orcid.org/0009-0005-4247-5412)
- N Aswani
- Galib Mirza Nasirul Islam
Institutions
- Brigham and Women's Hospital (US)
- Memorial Sloan Kettering Cancer Center (US)
- Emory University (US)
- Universidade de São Paulo (BR)
- Washington University in St. Louis (US)
- Rabindranath Tagore Medical College (IN)
- Mallinckrodt (United States) (US)
- Mayo Clinic Hospital (US)
- Hospital Universitário da Universidade de São Paulo (BR)
- University of Iowa Health Care (US)
- King Edward Memorial Hospital Research Centre (IN)
- Duke University Hospital (US)
Publication Details
- Journal
- Radiographics
- Published
- 2026-06-25
- DOI
- https://doi.org/10.1148/rg.250179
- Primary Topic
- Histiocytic Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute